Washed Microbiota Transplantation Combined With Enteral Nutrition for Gastroptosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorThe Second Hospital of Nanjing Medical University
About this trial
This is a observational study to explore the efficacy and safety of washed microbiota transplantation (WMT) combined with nutritional support for gastroptosis patients
Eligibility criteria
Qualifiers
Clinically diagnosed with gastroptosis;
Weight loss (weight loss >5% within the last 6 months or >10% over more than 6 months);
Low BMI (BMI <18.5 kg/m² for individuals <70 years old; BMI <20 kg/m² for individuals ≥70 years old);
Males aged ≥18 years and non-pregnant, non-lactating females aged ≥18 years;
Disqualifiers
Patients with severe depression, anxiety, or cognitive impairment that affects normal physician-patient communication and treatment planning;
Patients with poor compliance who cannot accept treatment regimens such as nasogastric enteral nutrition;
Anticipated survival time <3 months;
Clinically significant cardiovascular diseases, including heart failure (NYHA Class III-IV), uncontrolled coronary artery disease, cardiomyopathy, arrhythmia, history of myocardial infarction, hemodynamic instability at enrollment, unstable vital signs, or anticipated risk events during treatment;
Trial design
Treatments tested in this trial
- Not listed
Trial groups
24 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov